project id: TCGA-UCEC; case submitter id: TCGA-QS-A5YQ; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.65; rna integrity number: 7.1; age at index: 55; days to birth: -20425; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1958; age at diagnosis: 20425; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 759.0; figo stage: Stage IIIA; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 43; days to sample procurement: 0; initial weight: 370.0; portion submitter id: TCGA-QS-A5YQ-01A-11; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;